Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System

NCT: NCT07477054 · NOT_YET_RECRUITING

NCT IDNCT07477054
StatusNOT_YET_RECRUITING
Start Date2026-10-31
Completion2028-09-30
SponsorLungpacer Medical Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑